Search The Medical Knowledge Base

Drug Details

BCG VACCINE (intradermal)

• Drug Class Description
  Live attenuated vaccines.
• Generic Name
  Mycobacterium bovis
• Presentation
  BCG Vaccine (percutaneous): Mycobacterium bovis, 50 - 250 million colony forming units per vial. BCG Vaccine (intradermal): Mycobacterium bovis, 8 - 26 million colony forming units per 10-dose vial.
• Description
  BCG Vaccine (percutaneous): powder. BCG Vaccine (intradermal): powder in multi-dose vial.
• Indications
  Active immunisation against tuberculosis.
• Adult Dosage
  BCG Vaccine (intradermal): 0.1 mL strictly by intradermal injection.
• Child Dosage
  

  BCG Vaccine (percutaneous): Neonates and young children only, by percutaneous vaccination using multiple puncture technique. BCG Vaccine (intradermal): Under 3 months, 0.05 mL; over 3 months, 0.1 mL. Both strictly by intradermal injection.

• Contra Indications
  Febrile illness, impaired immunity, widespread malignancy, tuberculin positive patients.
• Special Precautions
  Pregnancy. Eczema. No further vaccination in BCG arm for 3 months due to risk of regional lymphadenitis.
• Interactions
  Corticosteroids, immunosuppressants, anti-TB therapy.
• Adverse Drug Reactions
  Rash, fever, local reactions, pain, lymphadenopathy, discharging ulcer.